Samlyn Capital, LLC Axonics, Inc. Transaction History

Samlyn Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $11.8 Million - $17.4 Million	-236,941 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $8.09 Million - $10.7 Million	-136,587 Reduced 36.57%	236,941 $15.4 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $4.9 Million - $6.37 Million	-95,286 Reduced 20.32%	373,528 $23.7 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $8.69 Million - $10.6 Million	-176,915 Reduced 27.4%	468,814 $28.1 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $2.15 Million - $2.62 Million	50,954 Added 8.57%	645,729 $32.2 Million
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $10.8 Million - $15.5 Million	-304,507 Reduced 33.86%	594,775 $30.4 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $5.08 Million - $8.84 Million	221,892 Added 32.76%	899,282 $31.6 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $2.62 Million - $6.01 Million	159,356 Added 30.76%	677,390 $17.2 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $10.1 Million - $15 Million	518,034 New	518,034 $14.4 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.